Dow Up1.05% Nasdaq Up1.74%

Aegerion Pharmaceuticals, Inc. (AEGR)

-NasdaqGS
31.57 Down 0.35(1.10%) 12:19PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 48,546   -   -  
Cost of Revenue5,019   -   -  
Gross Profit 43,527   -   -  
Operating Expenses
Research Development29,788  25,164  24,433  
Selling General and Administrative76,082  34,077  13,966  
Non Recurring4  1,366  912  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (62,347) (60,607) (39,311)
Income from Continuing Operations
Total Other Income/Expenses Net58  (721)957  
Earnings Before Interest And Taxes(62,289)(61,328)(38,354)
Interest Expense722  937  1,114  
Income Before Tax(63,011)(62,265)(39,468)
Income Tax Expense347   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(63,358)(62,265)(39,468)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (63,358) (62,265) (39,468)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (63,358) (62,265) (39,468)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.